| Chronic Myelogenous Leukemia |
1 |
0.85 |
| Antineoplastic Drug |
0 |
0.67 |
| Tyrosine Kinase Inhibitor |
0 |
0.67 |
| A-Scan Biometry |
0 |
0.59 |
| Scan |
0 |
0.59 |
| Biologic Therapy |
0 |
0.52 |
| Blood |
0 |
0.39 |
| Cancer |
0 |
0.39 |
| COVID-19 Vaccine |
0 |
0.36 |
| COVID-19 |
0 |
0.32 |
| Vaccines |
0 |
0.31 |
| Care and Maintenance of Vision |
0 |
0.23 |
| Cataract |
0 |
0.23 |
| Chemotherapy |
0 |
0.2 |
| Pandemic |
0 |
0.2 |
| T-Lymphocyte |
0 |
0.2 |
| Tyrosine Kinase |
0 |
0.2 |